South America Sepsis Diagnostics Market Forecast to 2028

Report Code : BMIRE00025666 | Region : LAMEA | Industry : Medical Device | Published Date : 10/Aug/2022
South America Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

The South America sepsis diagnostics market is expected to grow from US$ 38.66 million in 2021 to US$ 69.59 million by 2028; it is estimated to grow at a CAGR of 8.8% from 2021 to 2028.

Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. Thus, the rising bloodstream infections will increase the adoption of sepsis diagnostic products. Sepsis has a high mortality and morbidity rate. According to an article published by the National Center for Biotechnology Information (NCBI) in February 2019, sepsis mortality rate was ~25–30%. Additionally, in September 2020, the World Health Organization (WHO) estimated that each year almost 50% of cases of sepsis occur among children, resulting in 2.9 million deaths. Most deaths can be prevented through early diagnosis and appropriate clinical management. These deaths are often a consequence of diarrheal diseases or lower respiratory infections. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, thereby supporting the sepsis diagnostics market growth during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America sepsis diagnostics market. The South America sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

South America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million )

South America Sepsis Diagnostics Market Segmentation

The South America sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media segment dominated the South America sepsis diagnostics market in 2021. In terms of technology, the market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the South America sepsis diagnostics market in 2021. Based on method, the South America sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the market in 2021. Based on test type, the South America sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the market in 2021. In terms of pathogen, the South America sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the market in 2021. Based on end user, the South America sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the market in 2021. Based on country, the South America sepsis diagnostics market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America sepsis diagnostics market in 2021.

Key players operating in the South America sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. by Altair.

The List of Companies - South America Sepsis Diagnostics Market

● Abbott

● F. HOFFMANN-LA ROCHE LTD.

● Immunexpress Inc.

● BD

● Danaher (Beckman Coulter)

● Luminex Corporation

● THERMO FISHER SCIENTIFIC INC.

● bioMerieux SA

● T2 Biosystems, Inc

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Sepsis Diagnostics Market – By Product

1.3.2 SAM Sepsis Diagnostics Market – By Technology

1.3.3 SAM Sepsis Diagnostics Market – By Method

1.3.4 SAM Sepsis Diagnostics Market – By Test Type

1.3.5 SAM Sepsis Diagnostics Market – By Pathogen

1.3.6 SAM Sepsis Diagnostics Market – By End User

1.3.7 SAM Sepsis Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Sepsis Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections

5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2 Market Restraints

5.2.1 Lack of Skilled Professionals

5.3 Market Opportunities

5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research

5.4 Future Trends

5.4.1 Rising Technological Advancements in Sepsis Diagnosis

5.5 Impact Analysis

6. Sepsis Diagnostics Market– SAM Analysis

6.1 SAM Sepsis Diagnostics Market Revenue Forecast and Analysis

7. SAM Sepsis Diagnostics Market – By Product

7.1 Overview

7.2 SAM Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3 Instruments

7.3.1 Overview

7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Reagents and Assays

7.4.1 Overview

7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Blood Culture Media

7.5.1 Overview

7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Software

7.6.1 Overview

7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. SAM Sepsis Diagnostics Market – By Technology

8.1 Overview

8.2 SAM Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3 Molecular Diagnostics

8.3.1 Overview

8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Polymerase Chain Reaction

8.3.2.1.1 Overview

8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1 Overview

8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Syndromic Panel-Based Testing

8.3.2.3.1 Overview

8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4 Microarrays

8.3.2.4.1 Overview

8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Flow Cytometry

8.4.1 Overview

8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Microfluidics

8.5.1 Overview

8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Immunoassay

8.6.1 Overview

8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biomarkers

8.7.1 Overview

8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Microbiology

8.8.1 Overview

8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Sepsis Diagnostics Market – By Method

9.1 Overview

9.2 SAM Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3 Automated Diagnostics

9.3.1 Overview

9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Conventional Diagnostics

9.4.1 Overview

9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Sepsis Diagnostics Market – By Test Type

10.1 Overview

10.2 SAM Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3 Point-of-Care Tests

10.3.1 Overview

10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4 Laboratory Tests

10.4.1 Overview

10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. SAM Sepsis Diagnostics Market – By Pathogen

11.1 Overview

11.2 SAM Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3 Bacterial Sepsis

11.3.1 Overview

11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4 Fungal Sepsis

11.4.1 Overview

11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. SAM Sepsis Diagnostics Market – By End User

12.1 Overview

12.2 SAM Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3 Hospitals

12.3.1 Overview

12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4 Pathology and Reference Laboratories

12.4.1 Overview

12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5 Others

12.5.1 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. SAM Sepsis Diagnostics Market – By Country Analysis

13.1 South And Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028

13.1.1 Overview

13.1.2 SAM Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

13.1.2.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.1.2.1.1 Overview

13.1.2.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.1.2.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)

13.1.2.1.4 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.2.1.4.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.2.1.5 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.2.1.6 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.2.1.7 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.2.1.8 Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.1.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.1.2.2.1 Overview

13.1.2.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

13.1.2.2.3 Argentina: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)

13.1.2.2.4 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.2.2.4.1 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.2.2.5 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.2.2.6 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.2.2.7 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.2.2.8 Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

13.1.2.3 Rest of South and Central America: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)

13.1.2.3.1 Overview

13.1.2.3.2 Rest of SAM: Sepsis Diagnostics Market– Revenue and Forecast to 2028 (US$ Mn)

13.1.2.3.3 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)

13.1.2.3.4 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.2.3.4.1 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.2.3.5 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.2.3.6 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.2.3.7 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.2.3.8 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

14. Sepsis Diagnostics Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies in the Sepsis Diagnostics Market (%)

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 Abbott

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 F. HOFFMANN-LA ROCHE LTD.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Immunexpress Inc.

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 BD

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 Danaher (Beckman Coulter)

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Luminex Corporation

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 THERMO FISHER SCIENTIFIC INC.

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 bioMerieux SA

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 T2 Biosystems, Inc.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 2.             Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 3.             Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 4.             Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 5.             Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 6.             Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 7.             Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 8.             Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 9.             Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10.          Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 11.          Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 12.          Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 13.          Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 14.          Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 15.          Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 16.          Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 17.          Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 18.          Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 19.          Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 20.          Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 21.          Rest of SAM: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 22.          Organic Developments in the Sepsis Diagnostics Market

Table 23.          Inorganic Developments in the Sepsis Diagnostics Market

Table 24.          Glossary of Terms

The List of Companies - South America Sepsis Diagnostics Market

● Abbott

● F. HOFFMANN-LA ROCHE LTD.

● Immunexpress Inc.

● BD

● Danaher (Beckman Coulter)

● Luminex Corporation

● THERMO FISHER SCIENTIFIC INC.

● bioMerieux SA

● T2 Biosystems, Inc

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM sepsis diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the SAM sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the SAM sepsis diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(South America Sepsis Diagnostics Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry